International Network of VENous Thromboembolism Clinical Research Networks
INVENT Endorsed PLATO-VTE Study (Prospective cohort study assessing diagnostic accuracy of platelet mRNA profiling for occult cancer in the setting of VTE) recruited 22 patients in November 2018 - increasing the total recruitment numbers to 346 globally! See study info...
Congratulations to Dr. Patrick Mismetti (INNOVTE Network) on winning the inaugural INVENT Dragons' Den Competition in Dublin, Ireland at ISTH SSC Meeting 2018. As the winner of the competition, Dr. Mismetti is awarded the $35,000 (CAD) INVENT Inter...
Submit your application by Friday, June 8, 2018 to compete in Dublin, Ireland at the INVENT Dragons' Den Competition at the 2018 ISTH SSC meeting. Enter for a chance to win the $35,000 International Collaboration Grant and/or receive INVENT Study Endorsement.
Competit...
Do you have a clinical VTE study in need of international collaboration?
Pitch your study in front of the 3 INVENT dragons and an audience at the INVENT Dragons' Den Competition in Dublin, Ireland for a chance to win the $35,000 International Collaboration Grant.
Click b...
Initial Strides for INVENT-VTE: Towards Global Collaboration in Accelerating Clinical Research in Venous Thromboembolism Full abstract: https://authors.elsevier.com/a/1WUtMBEfCZLQg
INVENT endorsement of clinical research studies in VTE competition to be held at 2018 ISTH SSC in Dublin. Deadline to submit proposals is May 1st, 2018. Competition details coming soon!
INVENT endorsed ALIFE2 study (Anticoagulants for Living Fetuses in Women with Recurrent Miscarriage and Inherited Thrombophilia) has recruited 131 participants, and is looking for potential sites and investigators! Click here to learn more about the study and how t...
INVENT endorsed COVET study(Comparison of Oral anticoagulants for extended VEnous Thromboembolism), funded by Patient-Centered Outcomes Research Institute (PCORI) is looking for potential sites and investigators in Canada and United States!
INVENT endorsed HIGHLOW study (Low-Molecular-Weight Heparin to Prevent Recurrent VTE in Pregnancy: A Randomized Trial of Two Doses) has now recruited 500 patients! The study requires 500 more patients and is looking for potential sites and investigators.
Subscribe